Chemoinformaics analysis of (2R,3S,4S,5R)-2,4,5-TRIHYDROXY-3-METHOXYHEXANAL
| Molecular Weight | 178.184 | nRot | 5 |
| Heavy Atom Molecular Weight | 164.072 | nRig | 17 |
| Exact Molecular Weight | 178.084 | nRing | 0 |
| Solubility: LogS | -4.855 | nHRing | 0 |
| Solubility: LogP | 0.598 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 25.0351 |
| nHD | 3 | BPOL | 16.6489 |
| QED | 0.063 |
| Synth | 6.086 |
| Natural Product Likeliness | 1.324 |
| NR-PPAR-gamma | 0.971 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.937 |
| Pgp-sub | 0.005 |
| HIA | 0.999 |
| CACO-2 | -4.756 |
| MDCK | 0.0000181 |
| BBB | 0.078 |
| PPB | 0.653146 |
| VDSS | 0.938 |
| FU | 0.27007 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.023 |
| CYP2c19-inh | 0.006 |
| CYP2c19-sub | 0.051 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.082 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.037 |
| CYP3a4-inh | 0.649 |
| CYP3a4-sub | 0.478 |
| CL | 7.161 |
| T12 | 0.919 |
| hERG | 0.004 |
| Ames | 0.49 |
| ROA | 0.002 |
| SkinSen | 0.986 |
| Carcinogencity | 0.477 |
| EI | 0.689 |
| Respiratory | 0.879 |
| NR-Aromatase | 0.806 |
| Antiviral | No |
| Prediction | 0.919557 |